Sotalol Market Analysis and Growth (2019-2025): By Key Companies Bayer, GSK, Bristol-Myers Squibb (BMS)

Los Angeles, CA -- (SBWIRE) -- 03/21/2019 -- Sotalol is a medication used to treat abnormal heart rhythms. Sotalol is a non-selective competitive beta-adrenergic receptor blocker that also exhibits Class III antiarrhythmic properties.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.